EA199800677A1 - Способ ингибирования опухоли толстой кишки - Google Patents

Способ ингибирования опухоли толстой кишки

Info

Publication number
EA199800677A1
EA199800677A1 EA199800677A EA199800677A EA199800677A1 EA 199800677 A1 EA199800677 A1 EA 199800677A1 EA 199800677 A EA199800677 A EA 199800677A EA 199800677 A EA199800677 A EA 199800677A EA 199800677 A1 EA199800677 A1 EA 199800677A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibiting tumor
tumor inhibits
inhibits
hexamethyleneimino
pyrrolidino
Prior art date
Application number
EA199800677A
Other languages
English (en)
Other versions
EA001104B1 (ru
Inventor
Мария Л. Брэнди
Франческо Тонелли
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199800677A1 publication Critical patent/EA199800677A1/ru
Publication of EA001104B1 publication Critical patent/EA001104B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Способ ингибирования рака толстой кишки, включающий введение млекопитающему, которое в этом нуждается, эффективного количества соединения, имеющего формулу (I), где Rи Rнезависимо представляют водород, -СН, (а) или (b), где Ar представляет необязательно замещенный фенил; Rвыбирается из группы, состоящей из пирролидино, гексаметиленимино и пиперидино; или его фармацевтически приемлемой соли или сольвата.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800677A 1996-01-29 1997-01-27 Способ ингибирования опухоли толстой кишки EA001104B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (2)

Publication Number Publication Date
EA199800677A1 true EA199800677A1 (ru) 1999-02-25
EA001104B1 EA001104B1 (ru) 2000-10-30

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800677A EA001104B1 (ru) 1996-01-29 1997-01-27 Способ ингибирования опухоли толстой кишки

Country Status (19)

Country Link
EP (1) EP0921799A4 (ru)
JP (1) JP2000503994A (ru)
KR (1) KR19990082054A (ru)
CN (1) CN1209745A (ru)
AR (1) AR010978A1 (ru)
AU (1) AU707892B2 (ru)
BR (1) BR9700778A (ru)
CO (1) CO4761062A1 (ru)
CZ (1) CZ235498A3 (ru)
EA (1) EA001104B1 (ru)
ID (1) ID15917A (ru)
IL (1) IL125521A (ru)
MX (1) MX9806036A (ru)
NO (1) NO983451D0 (ru)
NZ (1) NZ331105A (ru)
PL (1) PL328147A1 (ru)
TW (1) TW446560B (ru)
WO (1) WO1997026877A1 (ru)
YU (1) YU2397A (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
KR950010891A (ko) * 1993-10-15 1995-05-15 피터 지. 스트링거 내성 종양을 치료하는 방법
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
NO983451L (no) 1998-07-27
EA001104B1 (ru) 2000-10-30
KR19990082054A (ko) 1999-11-15
AU707892B2 (en) 1999-07-22
YU2397A (en) 1999-11-22
ID15917A (id) 1997-08-21
CO4761062A1 (es) 1999-04-27
MX9806036A (es) 1998-11-29
IL125521A0 (en) 1999-03-12
CN1209745A (zh) 1999-03-03
PL328147A1 (en) 1999-01-18
EP0921799A4 (en) 2002-03-13
IL125521A (en) 2001-11-25
JP2000503994A (ja) 2000-04-04
EP0921799A1 (en) 1999-06-16
AR010978A1 (es) 2000-08-02
CZ235498A3 (cs) 1999-02-17
BR9700778A (pt) 1998-10-06
AU2123997A (en) 1997-08-20
NO983451D0 (no) 1998-07-27
NZ331105A (en) 2000-06-23
TW446560B (en) 2001-07-21
WO1997026877A1 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
EA200200873A1 (ru) Новые пиперазиновые производные
KR950010888A (ko) 평활근세포 증식 및 재발협착증을 억제하는 방법
EA200100983A1 (ru) Производные 13-метилэритромицина
EA199700450A1 (ru) Способы подавления миграции сосудистых гладкомышечных клеток
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
ATE168887T1 (de) Hemmung von dysfunctionalen uterusblutungen
DK0652004T3 (da) Fremgangsmåder til behandling af resistente neoplasmer
RU98113525A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования тромботического расстройства, для увеличения активации протеина с
RU2000124402A (ru) Производные азетидина и пирролидина
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
EA199900431A1 (ru) Способ профилактики рака молочной железы
EA199800019A1 (ru) Способ повышения плотности кальциевых каналов
EA199800015A1 (ru) Способ ингибирования меланомы
ATE207748T1 (de) Hemmung einer fehlentwicklung der ovarien, verspüteter pubertät oder sexuellem infantilismus
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
EA199800366A1 (ru) Способы ингибирования ингибитора 1 активатора плазминогена
EA199700200A1 (ru) Способы ингибирования рака яичника
EA199800677A1 (ru) Способ ингибирования опухоли толстой кишки
EA200000243A1 (ru) Способы снижения количества тромбоцитов
EA199800678A1 (ru) Способ ингибирования мышечно-апоневротических фиброматозов (десмоидных опухолей)
EA199800676A1 (ru) Способы повышения компетенции сфинктера
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
MX9701327A (es) Metodos para inhibir el cancer endometrial.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU